Global /Japan /Healthcare /Medical Distribution /3386
chevron_leftBack
Cosmo Bio Company,Ltd. logo

Cosmo Bio Company,Ltd.

3386
TSE: 3386 Delayed
1,275JPY 0.2%
7.97 USD
As of 5 June 2026, Cosmo Bio Company,Ltd. has a market cap of $45.09M USD, ranking #31341 globally and #2944 in Japan. It ranks #2834 in the Healthcare sector, and #116 in the Medical Distribution industry.
Global Rank
31341
Country Rank
2944
Sector Rank
2834
Industry Rank
116
Key Stats
Market Cap
$45.09MUSD
7.22B JPY
Enterprise Value
$30.45MUSD
4.87B JPY
Revenue (TTM)
$67.28MUSD
10.77B JPY
EBITDA (TTM)
$3.19MUSD
510.0M JPY
Net Income (TTM)
$2.11MUSD
337.0M JPY
EBITDA Margin
4.7%
Profit Margin
3.1%
PE Ratio
21.5
PS Ratio
0.7
PB Ratio
0.7
EV/EBITDA
9.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Norihiko Shibayama open_in_new
Employees
182
Founded
1978
Website
cosmobio.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.2% 1.5% 1.3% -3.5% 8.1% 12%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
3386
コスモ・バイオ株式会社
ISIN: JP3298700000
Shares Out.:
5.673M1 Shares Float: 2.127M2
TV:
SA:
YF:
GF:
BA:
MS:
1,275 JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Cosmo Bio Company,Ltd.

Cosmo Bio Company,Limited, together with its subsidiaries, operates as a life science trading company worldwide. It is involved in the import, export, manufacture, marketing, sales, and customer support of life science research bio tools, such as reagents, kits, instruments, and software. The company also distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, and bacteria, as well as detection reagents, cell and tissue culture systems, and gene analysis systems; and research instruments, including electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software. In addition, it provides drug discovery and custom research services; clinical diagnostics; cell and DNA, and protein engineering solutions; disposable items and general labware; and bioactive substances; consigned services, such as intestinal flora analysis, tear fluid analysis, and cell assays services; and custom peptide synthesis and antibody production services. Further, the company manufactures and sells cell/cell culture products comprising adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem cells, feeder cells, tumor cell lines, macrophage-related, and coating reagents; measurement and staining kits, detection/purification kits related to neurodementia, macrophage/immune, exosome, and anti-saccharification/anti-aging; and biotechnology research equipment, such as constant-temperature transport containers, aluminum block mat heat insulation devices, and dew condensation prevention glass plate. It serves universities, public research institutes, and companies engaged in biological science. Cosmo Bio Company, Limited was founded in 1978 and is headquartered in Koto, Japan.

Similar Companies

Industry: Medical Distribution (Japan)
Name
Market Cap diff.
PE
$3.61B
577.66B JPY
8K%
14.1
$2.72B
434.49B JPY
6K%
12.9
9987
$2.35B
376.13B JPY
5K%
11.3
8283
$1.77B
283.73B JPY
4K%
13.1
$1.77B
282.49B JPY
4K%
12.2
8086
$1.56B
250.11B JPY
3K%
18.6
Industry: Medical Distribution (Global)
Name
Market Cap diff.
PE
MCK
$100.76B
223K%
24.0
COR
$60.58B
134K%
37.4
$47.73B
106K%
29.6
HSIC
$8.47B
19K%
22.6
$7.48B
58.61B HKD
16K%
7.2
GALE
$5.3B
4.2B CHF
12K%
23.0
chevron_leftBack